The Ninth Circuit Court of Appeals will decide whether UnitedHealth can continue using a legal defense to avoid liability in a class action alleging deceptive sales of Medicare Advantage plans. Plaintiffs claim UnitedHealth misled seniors into abandoning Original Medicare, resulting in denied treatments and financial harm. The case challenges the use of CMS regulatory preemption after a 2024 Supreme Court ruling, with potential implications for corporate accountability in healthcare fraud. The court's decision could reinstate claims affecting hundreds of thousands of seniors nationwide.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
